Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.7422 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68129 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.671 | 29 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.66216 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.66963 | 32 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.85667 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.8333 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.67414 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.67291 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.65774 | 29 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66426 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.63008 | 29 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.67637 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67714 | 30 |